A detailed history of Cormorant Asset Management, LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Cormorant Asset Management, LP holds 400,000 shares of SLN stock, worth $2.84 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
400,000
Previous 625,000 36.0%
Holding current value
$2.84 Million
Previous $11.9 Million 38.73%
% of portfolio
0.51%
Previous 0.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.53 - $21.74 $3.49 Million - $4.89 Million
-225,000 Reduced 36.0%
400,000 $7.28 Million
Q1 2024

May 15, 2024

BUY
$17.39 - $26.25 $10.9 Million - $16.4 Million
625,000 New
625,000 $13.5 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $255M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.